Elevated pretreatment serum biomarkers and correlation with progression-free(PFS) and overall survival (OS) in first-line trastuzumab-treated metastatic breast cancer

被引：0
|
作者：
Ali, Suhail M.
Leitzel, Kim
Anyanwu, Uchechi
Hou, Hui Ying
Evans, Matthew Stephen
Shrivastava, Vika
Koeztler, Wolfgang
Fuchs, Eva-Maria
Esteva, Francisco J.
Carney, Walter P.
Lipton, Allan
机构：
[1] Penn State Hershey Med Ctr, Hershey, PA USA
[2] Med Univ Vienna, Vienna, Austria
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] WILEX Oncogene Sci, Cambridge, MA USA
[5] Penn State Milton S Hershey Med Ctr, Hershey, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
622
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Elevated pretreatment serum activin A and progression-free and overall survival in trastuzumab-treated metastatic breast cancer
    Zubritsky, Lindsey
    Leitzel, Kim
    Ali, Suhail M.
    Kstler, Wolfgang
    Fuchs, Eva-Maria
    Costa, Luis
    Knight, Robert D.
    Laadem, Abderrahmane
    Sherman, Matthew L.
    Lipton, Allan
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (30)
  • [2] Elevated pretreatment serum activin A and progression-free and overall survival in trastuzumab-treated metastatic breast cancer.
    Lipton, Allan
    Zubritsky, Lindsey
    Leitzel, Kim
    Ali, Suhail M.
    Koestler, Wolfgang
    Fuchs, Eva-Maria
    Costa, Luis
    Knight, Robert D.
    Laadem, Abderrahmane
    Sherman, Matthew L.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] Pretreatment serum metabolome predicts PFS in first-line trastuzumab-treated metastatic breast cancer
    O'Day, Elizabeth
    Leitzel, Kim
    Ali, Suhail M.
    Zhang, Bo
    Dong, Chen
    Gu, Haiwei
    Shi, Xiajian
    Drabick, Joseph J.
    Cream, Leah
    Vasekar, Monali
    Polimera, Hyma V.
    Nagabhairu, Vinod
    Moku, Prashanth
    Maddukuri, Ashok
    Menon, Harry
    Pancholy, Neha
    Carney, Walter P.
    Koestler, Wolfgang
    Lipton, Allan
    CANCER RESEARCH, 2020, 80 (04)
  • [4] Elevated Serum Ferritin Predicts Reduced Progression-Free and Overall Survival in Trastuzumab-Treated Metastatic Breast Cancer.
    Alkhateeb, A. A.
    Connor, J.
    Leitzel, K.
    Ali, S.
    Campbell-Baird, C.
    Evans, M.
    Koestler, W.
    Fuchs, E-M
    Lipton, A.
    CANCER RESEARCH, 2011, 71
  • [5] Elevated pretreatment serum CA9 (carbonic anhydrase 9) and correlation with progression-free and overall survival in trastuzumab-treated metastatic breast cancer.
    Leitzel, K.
    Hou, H. Y.
    Anyanwu, U.
    Shrivastava, V.
    Evans, M. S.
    Ali, S. M.
    Koestler, W.
    Fuchs, E.
    Esteva, F. J.
    Carney, W. P.
    Lipton, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [6] Use of serum uPA change to predict PFS and overall survival in first-line trastuzumab-treated breast cancer
    Hou, H. Y.
    Anyanwu, U.
    Jamshidi, N.
    Leitzel, K.
    Ali, S. M.
    Koestler, W.
    Fuchs, E.
    Hamer, P.
    Carney, W. P.
    Lipton, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Elevated Pretreatment Serum CA9 (CAIX) (Carbonic Anhydrase 9) Predicts Reduced Progression-Free and Overall Survival in Trastuzumab-Treated Metastatic Breast Cancer
    Anyanwu, U. I.
    Hou, H. Y.
    Shrinvastava, V.
    Evans, M.
    Leitzel, K.
    Ali, S. M.
    Koestler, W.
    Fuchs, E-M
    Brown-Shimer, S.
    Ramirez, J.
    Hamer, P.
    Carney, W.
    Kalu, R.
    Repich, K.
    Rizvi, S.
    Lipton, A.
    CANCER RESEARCH, 2010, 70
  • [8] Serum endoglin and uPA change predicts PFS and overall survival in first line trastuzumab-treated breast cancer
    Evans, Matthew S.
    Hou, Hui Ying
    Anyanwu, Uchechi
    Leitzel, Kim
    Ali, Suhail M.
    Koestler, Wolfgang
    Fuchs, Eva-Maria
    Brown-Shimer, Sheryl
    Hamer, Peter
    Carney, Walter
    Lipton, Allan
    CANCER RESEARCH, 2011, 71
  • [9] Elevated pretreatment serum TIMP-1 level predicts reduced PFS and overall survival in trastuzumab-treated metastatic breast cancer patients
    Anyanwu, Uchechi
    Hou, Hui
    Evans, Matthew
    Kostler, Wolfgang
    Fuchs, Eva-Maria
    Ali, Suhail
    Leitzel, Kim
    Demers, Laurence
    Hamer, Peter
    Pierce, Karen
    Brown-Shimer, Sheryl
    Carney, Walter
    Lipton, Allan
    CANCER RESEARCH, 2009, 69
  • [10] Trastuzumab Beyond Progression for HER2 Positive Metastatic Breast Cancer: Progression-Free Survival on First-Line Therapy Predicts Overall Survival Impact
    Rayson, Daniel
    Lutes, Sarah
    Walsh, Gordon
    Sellon, Marlene
    Colwell, Bruce
    Dorreen, Mark
    Drucker, Arik
    Jeyakumar, Alwin
    Younis, Tallal
    BREAST JOURNAL, 2014, 20 (04): : 408 - 413
12345